Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.
peer reviewed ; INTRODUCTION: A substantial proportion of SGA patients present with a syndrome underlying their growth restriction. Most SGA cohorts comprise both syndromic and non-syndromic patients impeding delineation of the recombinant human growth hormone (rhGH) response. We present a detailed characterization of a SGA cohort and analyze rhGH response based on adult height (AH). METHODS: Clinical and auxological data of SGA patients treated with rhGH, who had reached AH, were retrieved from BELGROW, a national database of all rhGH treated patients held by BESPEED (BElgian Society for PEdi... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 2023 |
Verlag/Hrsg.: |
Frontiers Media S.A.
|
Schlagwörter: | Growth Hormone / Human Growth Hormone / Recombinant Proteins / Infant / Newborn / Female / Adult / Humans / Child / Human Growth Hormone/therapeutic use / Belgium/epidemiology / Gestational Age / Fetal Growth Retardation/drug therapy / Diseases/drug therapy / adult height / children / growth / short for gestational age / short stature / syndromic / Human health sciences / Endocrinology / metabolism & nutrition / Pediatrics / Sciences de la santé humaine / Endocrinologie / métabolisme & nutrition / Pédiatrie |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26504364 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/311585 |